Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Manage your formulary budget
Find generic entry opportunities
|Title:||Compositions for the sustained-release of chlorhexidine|
|Abstract:||The present invention pertains to biodegradable sustained-release compositions capable of achieving the sustained release of chlorhexidine. The compositions can be formed into implant devices which may be used to treat a wide variety of diseases and conditions. The implants are especially useful in treating diseases such as periodontal disease which require prolonged drug release.|
|Inventor(s):||Friedman; Michael (Jerusalem, IL)|
|Assignee:||Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL)|
Patent Claim Types:|
see list of patent claims
|Composition; Device; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.